In recent years, there has been a growing interest in the potential benefits of psychedelic substances for mental health treatment and personal growth. As people seek alternatives to traditional pharmaceuticals and therapies, the exploration of these mind-altering substances has gained traction. But where can one legally access these substances for therapeutic or recreational purposes? Enter
Australia has become the first country in the world to legally allow doctors to prescribe specific psychedelic compounds to patients suffering from depression or post-traumatic stress disorder (PTSD). As the global conversation around psychedelic substances continues to evolve, Down Under has emerged as a captivating destination for those seeking inner awakening and personal growth. With
The U.S. Food and Drug Administration released a new draft guidance for researchers looking into psychedelic medicines to potentially treat medical illnesses, such as psychiatric or substance use disorders, highlighting important factors. This is the first FDA draft guidance offering industry advice on planning clinical trials for psychedelic medications. In recent years, there has been an increase
On January 5, 2022, Health Canada announced that effective immediately, certain regulatory amendments are being put into place which will permit the possibility for practitioners who are allowed to prescribe drugs to request access to restricted drugs through Health Canada’s Special Access Program (SAP). Health Canada’s Special Access Program will allow these qualified healthcare practitioners
Subscribe To Our Newsletter
Get Latest Industry News and Updates
![Canada](/wp-content/uploads/2022/03/canada_ico.png"){kind=small}